Application of Biophysical Techniques to Cellular and Molecular Oncology

Diane S Lidke1, Jennifer M Gillette1, Alessandra Cambi2

  • 1Department of Pathology and Comprehensive Cancer Center, School of Medicine, University of New Mexico, Albuquerque, NM 87102, USA.

Cancers
|June 10, 2023
PubMed

Insights

Disrupted cellular processes are key drivers of cancer development, spread, and treatment resistance. Understanding these mechanisms is crucial for advancing cancer therapies.

Area of Science:

  • Cellular Biology
  • Cancer Research
  • Molecular Oncology

Background:

  • Cellular processes are fundamental to organismal health.
  • Dysregulation of these processes can lead to diseases like cancer.
  • Understanding these disruptions is critical for therapeutic development.

Discussion:

  • Malignant transformation is driven by aberrant cellular functions.
  • Tumor progression and metastasis are complex cellular events.
  • Cellular process dysregulation impacts therapeutic efficacy.

Key Insights:

  • Specific cellular pathways are implicated in cancer initiation.
  • Metastatic cascades involve coordinated cellular changes.
  • Predicting and overcoming treatment resistance requires knowledge of cellular mechanisms.

Outlook:

  • Targeting dysregulated cellular processes offers novel therapeutic strategies.
  • Further research will elucidate specific molecular targets.
  • Personalized medicine approaches may leverage this understanding.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K